Chelsea Therapeutics International's CEO Discusses Q4 2011 Results - Earnings Call Transcript

Chelsea Therapeutics International, Ltd. ( CHTP)

Q4 2011 Earnings Call

March 6, 2012 4:30 pm ET


Kate McNeil - Director, IR

Simon Pedder - President and CEO

Nick Riehle - CFO

Art Hewitt - CSO

Bill Schwieterman - CMO

Keith Schmidt - VP, Marketing and Sales


Robyn Karnauskas - Deutsche Bank

Liana Moussatos - Wedbush Securities

Alan Carr - Needham & Company

Jonathan Eckard - Leerink Swann

Juan Sanchez - Ladenburg



Good day, and welcome to the Chelsea Therapeutics International fourth quarter conference call. (Operator Instructions) I would now like to introduce the host for today's conference, Ms. Kate McNeil, Director of Investor Relations.

Kate McNeil

Good afternoon and welcome to Chelsea Therapeutics fourth quarter and full year 2011 conference call. We announced our fourth quarter full year 2011 results this afternoon after the close of the U.S. financial markets and our press release can be found on our website at

Joining me from Chelsea Therapeutics is Dr. Simon Pedder, President and Chief Executive Officer; Mr. Nick Riehle, Chief Financial Officer; Dr. Art Hewitt, Chief Scientific Officer; Dr. Bill Schwieterman, Chief Medical Officer; and Mr. Keith Schmidt, Vice President of Marketing and Sales.

Before I turn the meeting over to Dr. Pedder, let me note that some of the remarks you'll hear today may contain forward-looking statements about the company's performance. Actual future results might differ materially from those projected in these forward-looking statements.

If you liked this article you might like

Lundbeck to Buy Chelsea Therapeutics for $658M

Why Chelsea Therapeutics (CHTP) Stock Is Soaring Today

Chelsea Exits in Victory With Lundbeck Takeout

Chelsea Therapeutics International Ltd. (CHTP) Shares Soar 14%

'Mad Money' Lightning Round: Zynga Can Go Higher